MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
30
Unique beneficiaries
—
Total services
84
Distinct HCPCS
2
Medicare payment
$7K
PRESCRIBING · PART D · 2024
Total Rx claims
41
Beneficiaries
—
Total drug cost
$39K
Distinct drugs
2
Brand share
100.0%
Top prescribed drugs
Tirzepatide23 claims
Semaglutide18 claims
QUALITY · MIPS · 2024
Final MIPS score
84.4
Quality
66.7
Cost
71.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.39%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE